Board Meeting Details
The Board of Directors meeting was held on October 30, 2026, from 4:00 PM to 5:00 PM, where the financial results were approved.
Financial Results Overview - Standalone (₹ in Lakhs)
Quarter Ended September 30, 2026:
- Revenue from Operations: 30,570.62
- Other Income: 817.94
- Total Income: 31,388.56
- Total Expenses: 27,312.28
- Profit Before Tax: 4,076.28
- Tax Expense: 980.97
- Net Profit After Tax: 3,095.31
- Other Comprehensive Income/(Loss): (39.04)
- Total Comprehensive Income: 3,056.27
- Basic EPS: ₹1.96 (not annualized)
- Diluted EPS: ₹1.96 (not annualized)
Half Year Ended September 30, 2026:
- Revenue from Operations: 58,771.59
- Other Income: 1,357.52
- Total Income: 60,129.11
- Total Expenses: 51,841.85
- Profit Before Tax: 8,287.26
- Tax Expense: 2,086.84
- Net Profit After Tax: 6,200.42
- Other Comprehensive Income/(Loss): (42.29)
- Total Comprehensive Income: 6,158.13
- Basic EPS: ₹3.92 (not annualized)
- Diluted EPS: ₹3.92 (not annualized)
Comparative Figures (Quarter Ended):
- September 30, 2025 Revenue: 26,978.31
- September 30, 2025 Net Profit: 2,996.45
- June 30, 2026 Revenue: 28,200.97
- June 30, 2026 Net Profit: 3,105.11
Financial Results Overview - Consolidated (₹ in Lakhs)
Quarter Ended September 30, 2026:
- Revenue from Operations: 31,104.14
- Other Income: 807.58
- Total Income: 31,911.72
- Total Expenses: 27,814.11
- Profit Before Tax: 4,097.61
- Tax Expense: 987.65
- Net Profit After Tax: 3,109.95
- Other Comprehensive Income/(Loss): (39.78)
- Total Comprehensive Income: 3,070.17
- Profit Attributable to Shareholders: 3,102.94
- Profit Attributable to Non-Controlling Interest: 7.02
- Basic EPS: ₹1.96 (not annualized)
- Diluted EPS: ₹1.96 (not annualized)
Half Year Ended September 30, 2026:
- Revenue from Operations: 59,836.49
- Other Income: 1,344.97
- Total Income: 61,181.46
- Total Expenses: 52,820.82
- Profit Before Tax: 8,360.64
- Tax Expense: 2,106.42
- Net Profit After Tax: 6,254.22
- Other Comprehensive Income/(Loss): (43.44)
- Total Comprehensive Income: 6,210.78
- Profit Attributable to Shareholders: 6,234.00
- Profit Attributable to Non-Controlling Interest: 20.22
- Basic EPS: ₹3.94 (not annualized)
- Diluted EPS: ₹3.94 (not annualized)
Segment Reporting
The company has one reportable business segment: "Healthcare Services".
Geographical Revenue (Standalone, ₹ in Lakhs):
- India Revenue (Q2 FY27): 21,693.41
- Outside India Revenue (Q2 FY27): 8,877.21
- Total Revenue (Q2 FY27): 30,570.62
Non-Current Assets by Geography (Standalone, ₹ in Lakhs):
- India: 1,10,340.62 (as of September 30, 2026)
- Outside India: Not applicable
Capital Structure and Financing
- Paid-up Equity Share Capital: ₹1,583.06 lakhs (Face value Re. 1/- each)
- The company had issued 33,000 CCDs aggregating ₹33,000 lakhs to International Finance Corporation through a preferential issue in April/May 2024, which converted into 1,89,62,247 equity shares on November 15, 2025.
- Out of the total proceeds, ₹16,470 lakhs (including ₹1,036 lakhs in the current quarter) have been utilized towards expansion, with the balance held in fixed deposits.
Dividend Information
During the quarter and six months ended September 30, 2026, the company paid a final dividend of ₹0.45 per fully paid-up equity share of ₹1 each, aggregating ₹712.38 lakhs, for the year ended March 31, 2026, as approved by shareholders.
Expansion Update
During the quarter, in July 2026, the company commenced operations (soft launch) of its new 300-bed multi-super speciality hospital at Raipur, Chhattisgarh.
Subsidiary Information
The consolidated results include Artemis Cardiac Care Private Limited, a subsidiary company. For the half year ended September 30, 2026, the subsidiary contributed:
- Total Assets: ₹2,233.11 lakhs
- Total Revenues: ₹1,066.40 lakhs
- Net Profit After Tax: ₹57.81 lakhs
- Net Cash Inflows: ₹45.81 lakhs
Auditor Review
The unaudited financial results were reviewed by the statutory auditors, T R Chadha & Co LLP, who issued an unmodified conclusion pursuant to Regulation 33 of SEBI Listing Regulations.
Financial Position (Standalone as of September 30, 2026)
- Total Assets: ₹1,59,249.00 lakhs
- Total Equity: ₹99,312.52 lakhs
- Non-current Liabilities: ₹34,038.37 lakhs
- Current Liabilities: ₹25,898.11 lakhs
- Cash and Cash Equivalents: ₹1,828.16 lakhs
Cash Flow (Standalone for H1 FY27)
- Net Cash from Operating Activities: ₹11,119.91 lakhs
- Net Cash Used in Investing Activities: ₹(12,074.86) lakhs
- Net Cash from Financing Activities: ₹(520.55) lakhs
- Net Decrease in Cash: ₹(1,475.50) lakhs